Trandolapril

Overview

Trandolapril is an angiotensin converting enzyme (ACE) inhibitor. It has a longer biological half-life and a high degree of lipophilicity than others. It is used to treat high blood pressure. It acts by competitive inhibition of ACE, which is a key enzyme in the renin-angiotensin system and plays an important role in regulating blood pressure. lt inhibits atherosclerosis1 and decreases the occurrence of atrial fibrillation2. It is marketed by Abbott Laboratories under the brand name Mavik. It has been listed. Sequence: Unk-Ala-Oic(3aR,7aS)-OH Source summary: Trandolapril for cardiovascular and hypertension research. High-quality synthesis, fast delivery, and customizable options for drug development studies.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Inflammation / Immunology | Angiotensin-converting Enzyme (ACE)

Product Information

• Catalog No.: B2693-078810
• CAS No.: 87679-37-6
• Molecular Formula: C24H34N2O5
• Molecular Weight: 430.53
• Purity: >98 %
• Storage: Store at RT
• Solubility: Soluble in DMSO

Source

Original product source